FDA approves first non-hormone therapy for excessive menstrual bleedingNovember 13th, 2009 more images
more imagesFDA approves new drug for heavy menstrual bleedingWASHINGTON — Federal health officials have approved a new drug as the first non-hormonal treatment for heavy menstrual bleeding. The Food and Drug Administration says Lysteda tablets reduce bleeding by acting on a protein that helps blood clot.
Teva Pharmaceutical receives FDA approval for generic version of heartburn drug PrevacidNovember 10th, 2009 more images
more imagesTeva gets FDA approval for generic PrevacidNEW YORK — Teva Pharmaceutical Industries Ltd. said Tuesday the Food and Drug Administration approved its generic version of the heartburn drug Prevacid.
How BP could go out of hand during winter breakOctober 25th, 2009 WASHINGTON - While winter holidays are just round the corner, there are chances that people with high blood pressure might risk their health by overindulging in the season, warns an expert. Dr. Shawna Nesbitt, hypertension specialist at UT Southwestern Medical Center, said that about one in four Americans has hypertension, a disease that elevates blood pressure and can lead to a host of serious problems including heart attacks and strokes.
Practicing yoga or tai chi daily improves overall healthOctober 24th, 2009 WASHINGTON - Practicing yoga or tai chi 20 minutes each morning can help reduce stress, improve strength, limberness, provide better immune function and lower blood pressure. The major benefit of yoga and tai chi is that they combine key elements of exercise - aerobic, strength training, core stability, flexibility and balance - into unified approaches.
Drugmaker Bristol-Myers posts higher 3Q sales, but lower profit due to $2B gain a year agoOctober 22nd, 2009 Bristol-Myers posts higher 3Q sales, lower profitTRENTON, N.J. — Drugmaker Bristol-Myers Squibb Co.
Bristol-Myers faces growing competition for key drugs as it reports 3Q resultsOctober 21st, 2009 Earnings Preview: Bristol-Myers 3Q earnings reportNEW YORK — Bristol-Myers Squibb Co., the world's No. 15 drug maker by revenue, reports earnings for the third quarter on Thursday morning.
FDA warns food producers about inaccurate nutritional claims on groceriesOctober 20th, 2009 FDA cracking down on inaccurate food labelsWASHINGTON — Federal health officials say nutritional logos from food manufacturers may be misleading consumers about the actual health benefits of cereal, crackers and other processed foods. The Food and Drug Administration issued a letter to companies that says the agency will begin cracking down on inaccurate food labeling.
Medco says it will run clinical trial to compare blood thinners Plavix and EffientOctober 19th, 2009 Medco plans to compare Plavix, Effient in studyNEW YORK — Medco Health Solutions Inc. said Tuesday it will compare the blood thinner Plavix, the world's second-best selling drug, with the newer Effient.
Heartburn drugs safe for foetuses, says Israeli studyOctober 8th, 2009 WASHINGTON - A new study done by Israeli scientists has shown that heartburn drugs are safe for the foetus. The study, conducted by researchers at the Ben-Gurion University of the Negev, Israel, has been published in the Journal of Clinical Pharmacology.
Saliva-based genetic test helps doctors identify patients who would not respond to PlavixOctober 7th, 2009 Test detects patients who don't respond to PlavixWASHINGTON — "Just spit." With those simple instructions, health care providers in California are hoping to expand the use of genetic testing to make sure patients get the right medication. Scripps Health hospital system has begun using a saliva-based genetic test to detect whether patients will respond to Plavix, a widely used blood thinner that usually prevents clots.
FDA tells doctors reformulated blood thinner heparin will be safer, but less potentOctober 1st, 2009 FDA tells doctors new heparin formula less potentWASHINGTON — The Food and Drug Administration is alerting doctors that a widely used blood thinner has been reformulated to improve its safety, though the change could open the door to dosing errors. The FDA said Thursday new heparin vials scheduled to begin shipping next week will be 10 percent less potent than the original blood thinner.
Drug rasagiline may slow Parkinson's progressionSeptember 24th, 2009 LONDON - Scientists from Mount Sinai School of Medicine have found that drug rasagiline not only helps treat the symptoms of Parkinson's Disease, but also slows the rate of disease progression. The study called ADAGIO (Attenuation of Disease Progression with Azilect Given Once Daily) showed that previously untreated PD patients randomized to initiate therapy with rasagiline (Azilect(r)) 1 mg per day had benefits at 18 months that were not achieved when the same drug was initiated at nine months.
Middle-aged smokers with high cholesterol, BP 'cut life short by 10yrs'September 18th, 2009 LONDON - Middle-aged smokers with high cholesterol and blood pressure face a ten-year cut in their lives, warns a new study. The warning follows an Oxford University study of 19,000 men over an average of 38 years.
As you age, muscles get hard to build, easy to loseSeptember 12th, 2009 LONDON - Why do people's arms and legs get thinner as they age?
According to a team from Nottingham University (N-U) Schools of Graduate Entry Medicine, it could be due to the body's failure to deliver nutrients and hormones to muscle because of poorer blood supply. The researchers have already shown that older people cannot make muscle as fast as the young.
Cancer safety fears of most common heartburn treatment rejectedSeptember 10th, 2009 WASHINGTON - The largest ever study on 'Proton pump inhibitors' (PPI)-the second most prescribed group of drugs for heartburn-has dismissed all fears about the cancer causing effects of the treatment. PPI are the most commonly used treatment for chronic acid reflux, or 'heartburn', a painful burning sensation in the chest, neck and throat which is experienced by almost a third of people in developed countries.
